SKHX Holds Its Recovery as SK Hynix's $29B Raise Becomes a Pure HBM Capex Bet

What the $29 Billion Actually Funds

SK Hynix's June 24 filing turns a rumored raise into hard terms: up to 17.79 million new shares for 45.45 trillion won, roughly $29.4 billion, one of the largest equity sales on record. The structure is the part worth reading. This is a *primary* issuance — brand-new shares, not insiders cashing out — at an indicative 2.555 million won per common share, or 255,500 won per ADR with ten ADRs to a share. And every won is earmarked for capacity: the Yongin semiconductor cluster, the Cheongju P&T7 advanced-packaging line, HBM production, and EUV scanners from ASML. BofA, Citi, Goldman Sachs and J.P. Morgan are running the book. Read plainly, this is not a shareholder-return story — it's SK Hynix raising a Micron-sized war chest to pour into the single most supply-constrained product in semis.

Why a Dilutive Raise Trades Bullish

Issuing ~17.79 million new shares is dilution, full stop, and a raise this large would normally cap a stock. SKHX did the opposite — SK Hynix surged roughly 11% in the session after the filing, extending a V-shaped recovery off the June 23 rout, when the KOSPI tripped its circuit breaker twice and Hynix fell more than 12% on Nvidia Rubin production-cut fears. Two things flip the sign. First, a Nasdaq line puts SK Hynix on the same board as Micron — the explicit goal being a US peer multiple instead of the long-standing Korea discount. Second, the capital lands in HBM at the exact moment AI-memory supply is the tightest it has been. A rumored 90 trillion won Samsung buyback added fuel, but the core read is simple: traders will fund accretive capacity all day.

One accuracy note: SKHX's +11.91% over 22 hours is wider than the underlying's ~3% June 24 session gain because the perp's window straddles the crash low. The asset is pricing the recovery arc, not a single up day.

What to Watch

The calendar is the catalyst now. The registration is expected to go effective around July 6, bookbuilding finalizes pricing, and ADRs are slated to begin trading July 10 with settlement on July 14. Final pricing is the first real test — the 255,500 won figure is only indicative, and a soft bookbuild into a ~$29 billion float is the obvious downside. There's also a structural wrinkle specific to this synthetic: SKHX's oracle marks off the Seoul KRW price, but starting July 10 a parallel US ADR print exists for the same equity. If the two diverge during US hours, SKHX tracks Seoul — not the Nasdaq tape — a basis to respect around the debut.